Literature DB >> 20717903

Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.

Yunfei Wang1, Anna M Ray, Emilie K Johnson, Kimberly A Zuhlke, Kathleen A Cooney, Ethan M Lange.   

Abstract

BACKGROUND: Prostate cancer is the most commonly diagnosed non-skin cancer in men in the United States and the second leading cause of cancer-related mortality. African American men have substantially increased risk of both being diagnosed and dying from the disease. Recent genome-wide genetic association studies have identified a number of common single nucleotide genetic polymorphisms (SNPs) that are associated with prostate cancer in men of European descent. Only a small number of studies have evaluated the association between these genetic variants and prostate cancer in African Americans.
METHODS: We used logistic regression models to assess the association between prostate cancer in African American men and 24 SNPs from regions previously reported to be associated with prostate cancer in men of European descent.
RESULTS: We found nominal evidence (P < 0.05) for association between prostate cancer and three chromosome 8q24 (rs6983561, rs16901979, and rs7000448) and two 10q11 (rs7904463 and rs10740051) SNPs.
CONCLUSIONS: We confirm recent reports that 8q24 variants identified to be associated with prostate cancer in men of European descent are also associated with prostate cancer in African Americans. Our report is the first to find evidence of association between SNPs near MSMB and prostate cancer in African Americans. Of note, rs7000448 is in strong linkage disequilibrium with rs10761581 in NCOA4, a SNP that has been implicated to be independently associated, with respect to the widely reported SNP rs10993994 in the nearby gene MSMB, with prostate cancer in men of European descent.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20717903      PMCID: PMC4851861          DOI: 10.1002/pros.21234

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  17 in total

1.  Association mapping in structured populations.

Authors:  J K Pritchard; M Stephens; N A Rosenberg; P Donnelly
Journal:  Am J Hum Genet       Date:  2000-05-26       Impact factor: 11.025

2.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

3.  A common variant associated with prostate cancer in European and African populations.

Authors:  Laufey T Amundadottir; Patrick Sulem; Julius Gudmundsson; Agnar Helgason; Adam Baker; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Jean-Baptiste Cazier; Jesus Sainz; Margret Jakobsdottir; Jelena Kostic; Droplaug N Magnusdottir; Shyamali Ghosh; Kari Agnarsson; Birgitta Birgisdottir; Louise Le Roux; Adalheidur Olafsdottir; Thorarinn Blondal; Margret Andresdottir; Olafia Svandis Gretarsdottir; Jon T Bergthorsson; Daniel Gudbjartsson; Arnaldur Gylfason; Gudmar Thorleifsson; Andrei Manolescu; Kristleifur Kristjansson; Gudmundur Geirsson; Helgi Isaksson; Julie Douglas; Jan-Erik Johansson; Katarina Bälter; Fredrik Wiklund; James E Montie; Xiaoying Yu; Brian K Suarez; Carole Ober; Kathleen A Cooney; Henrik Gronberg; William J Catalona; Gudmundur V Einarsson; Rosa B Barkardottir; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2006-05-07       Impact factor: 38.330

4.  The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models.

Authors:  R C Lewontin
Journal:  Genetics       Date:  1964-01       Impact factor: 4.562

5.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Authors:  Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

6.  Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.

Authors:  Stanley Hooker; Wenndy Hernandez; Hankui Chen; Christiane Robbins; Jada Benn Torres; Chiledum Ahaghotu; John Carpten; Rick A Kittles
Journal:  Prostate       Date:  2010-02-15       Impact factor: 4.104

Review 7.  Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.

Authors:  K A Cooney; M S Strawderman; K J Wojno; K M Doerr; A Taylor; K H Alcser; S G Heeringa; J M Taylor; J T Wei; J E Montie; D Schottenfeld
Journal:  Urology       Date:  2001-01       Impact factor: 2.649

8.  Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

Authors:  David Duggan; Siqun L Zheng; Michele Knowlton; Debbie Benitez; Latchezar Dimitrov; Fredrik Wiklund; Christiane Robbins; Sarah D Isaacs; Yu Cheng; Ge Li; Jielin Sun; Bao-Li Chang; Leslie Marovich; Kathleen E Wiley; Katarina Bälter; Pär Stattin; Hans-Olov Adami; Marta Gielzak; Guifang Yan; Jurga Sauvageot; Wennuan Liu; Jin Woo Kim; Eugene R Bleecker; Deborah A Meyers; Bruce J Trock; Alan W Partin; Patrick C Walsh; William B Isaacs; Henrik Grönberg; Jianfeng Xu; John D Carpten
Journal:  J Natl Cancer Inst       Date:  2007-12-11       Impact factor: 13.506

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Prostate cancer risk associated loci in African Americans.

Authors:  Jianfeng Xu; Adam S Kibel; Jennifer J Hu; Aubrey R Turner; Kristen Pruett; Siqun Lilly Zheng; Jielin Sun; Sarah D Isaacs; Kathleen E Wiley; Seong-Tae Kim; Fang-Chi Hsu; William Wu; Frank M Torti; Patrick C Walsh; Bao-Li Chang; William B Isaacs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-23       Impact factor: 4.254

View more
  13 in total

1.  8q24 risk alleles and prostate cancer in African-Barbadian men.

Authors:  Cheryl D Cropp; Christiane M Robbins; Xin Sheng; Anselm J M Hennis; John D Carpten; Lyndon Waterman; Ronald Worrell; Tae-Hwi Schwantes-An; Jeffrey M Trent; Christopher A Haiman; M Cristina Leske; Suh-Yuh Wu; Joan E Bailey-Wilson; Barbara Nemesure
Journal:  Prostate       Date:  2014-09-22       Impact factor: 4.104

2.  8q24 risk alleles in West African and Caribbean men.

Authors:  Adam B Murphy; Flora Ukoli; Vincent Freeman; Frankly Bennett; William Aiken; Trevor Tulloch; Kathleen Coard; Fru Angwafo; Rick A Kittles
Journal:  Prostate       Date:  2012-01-10       Impact factor: 4.104

3.  Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk.

Authors:  Erika M Kwon; Sarah K Holt; Rong Fu; Suzanne Kolb; Gabrielle Williams; Janet L Stanford; Elaine A Ostrander
Journal:  Cancer Epidemiol       Date:  2012-04-26       Impact factor: 2.984

4.  Fine-mapping of IL16 gene and prostate cancer risk in African Americans.

Authors:  Ken Batai; Ebony Shah; Adam B Murphy; Jennifer Newsome; Maria Ruden; Chiledum Ahaghotu; Rick A Kittles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-24       Impact factor: 4.254

5.  Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects.

Authors:  Xiang Ao; Ying Liu; Xiao-Yan Bai; Xinjian Qu; Zhaowei Xu; Gaolei Hu; Min Chen; Huijian Wu
Journal:  Onco Targets Ther       Date:  2015-07-07       Impact factor: 4.147

6.  Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies).

Authors:  Geraldine Cancel-Tassin; Marc Romana; Cecile Gaffory; Pascal Blanchet; Olivier Cussenot; Luc Multigner
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

7.  An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer.

Authors:  Karen S Bishop; Dug Yeo Han; Nishi Karunasinghe; Megan Goudie; Jonathan G Masters; Lynnette R Ferguson
Journal:  PeerJ       Date:  2016-03-01       Impact factor: 2.984

8.  Comprehensive functional annotation of 77 prostate cancer risk loci.

Authors:  Dennis J Hazelett; Suhn Kyong Rhie; Malaina Gaddis; Chunli Yan; Daniel L Lakeland; Simon G Coetzee; Brian E Henderson; Houtan Noushmehr; Wendy Cozen; Zsofia Kote-Jarai; Rosalind A Eeles; Douglas F Easton; Christopher A Haiman; Wange Lu; Peggy J Farnham; Gerhard A Coetzee
Journal:  PLoS Genet       Date:  2014-01-30       Impact factor: 5.917

9.  Cumulative evidence of relationships between multiple variants in 8q24 region and cancer incidence.

Authors:  Yu Tong; Ying Tang; Shiping Li; Fengyan Zhao; Junjie Ying; Yi Qu; Xiaoyu Niu; Dezhi Mu
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

10.  Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP.

Authors:  Stéphane Supiot; Loic Campion; Pascal Pommier; Mélanie Dore; Clément Palpacuer; Séverine Racadot; Emmanuel Rio; Gérard A Milano; Céline Mahier-Ait Oukhatar; Christian Carrie
Journal:  Oncotarget       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.